Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision label changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:29:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section with the Iowa site details. Removed the Iowa Locations block and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:43:03.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.3.2 and removed Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:16.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice banner that warned users about possible delays and operating status changes. The banner previously conveyed site-wide operational information.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:31.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No additions or deletions were detected for the study page (NCT03957551) in the provided screenshots and text; the page content appears unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T21:32:19.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:12:24.000Z thumbnail image

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.